HUE036586T2 - Õssejtek szabályozása - Google Patents
Õssejtek szabályozásaInfo
- Publication number
- HUE036586T2 HUE036586T2 HUE05817711A HUE05817711A HUE036586T2 HU E036586 T2 HUE036586 T2 HU E036586T2 HU E05817711 A HUE05817711 A HU E05817711A HU E05817711 A HUE05817711 A HU E05817711A HU E036586 T2 HUE036586 T2 HU E036586T2
- Authority
- HU
- Hungary
- Prior art keywords
- stem cells
- composition
- matter
- regulating stem
- dim
- Prior art date
Links
- 230000001105 regulatory effect Effects 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 abstract 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 abstract 1
- 101000608935 Homo sapiens Leukosialin Proteins 0.000 abstract 1
- 102100039564 Leukosialin Human genes 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Mushroom Cultivation (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63639104P | 2004-12-14 | 2004-12-14 | |
| US66873905P | 2005-04-05 | 2005-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE036586T2 true HUE036586T2 (hu) | 2018-07-30 |
Family
ID=36588272
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE10190450A HUE047870T2 (hu) | 2004-12-14 | 2005-12-14 | Neurális eredetû sejtek elõállítása vérbõl |
| HUE10192785A HUE039132T2 (hu) | 2004-12-14 | 2005-12-14 | Õssejtek szabályozása |
| HUE05817711A HUE036586T2 (hu) | 2004-12-14 | 2005-12-14 | Õssejtek szabályozása |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE10190450A HUE047870T2 (hu) | 2004-12-14 | 2005-12-14 | Neurális eredetû sejtek elõállítása vérbõl |
| HUE10192785A HUE039132T2 (hu) | 2004-12-14 | 2005-12-14 | Õssejtek szabályozása |
Country Status (13)
| Country | Link |
|---|---|
| EP (4) | EP2292733B1 (hu) |
| AT (1) | ATE521699T1 (hu) |
| CA (3) | CA2632834C (hu) |
| CY (1) | CY1122586T1 (hu) |
| DK (1) | DK2292733T3 (hu) |
| ES (1) | ES2763357T3 (hu) |
| HU (3) | HUE047870T2 (hu) |
| LT (1) | LT2292733T (hu) |
| PL (1) | PL2292733T3 (hu) |
| PT (1) | PT2292733T (hu) |
| SI (1) | SI2292733T1 (hu) |
| TW (1) | TW200819534A (hu) |
| WO (2) | WO2006064504A2 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200734462A (en) * | 2006-03-08 | 2007-09-16 | In Motion Invest Ltd | Regulating stem cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878543B1 (en) * | 1999-10-25 | 2005-04-12 | Nsgene Sa | Cultures of GFAP+ nestin+ cells that differentiate to neurons |
| US6810286B2 (en) | 2000-03-06 | 2004-10-26 | Medtronic, Inc | Stimulation for delivery of molecular therapy |
| US8273570B2 (en) * | 2000-05-16 | 2012-09-25 | Riken | Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells |
| CA2396536A1 (en) * | 2001-08-10 | 2003-02-10 | Saiko Uchida | Human stem cells originated from human amniotic mesenchymal cell layer |
| DE60236016D1 (de) * | 2001-12-21 | 2010-05-27 | Mount Sinai Hospital Corp | Zelluläre zusammensetzungen und verfahren zur deren bereitung und verwendung |
| AU2002315259A1 (en) * | 2002-03-20 | 2003-09-29 | Miltenyi Biotec Gmbh | A method for generating human nervous system cells, tissues, or neural stem cell progenitors from haematopoietic stem cells |
-
2005
- 2005-12-14 CA CA2632834A patent/CA2632834C/en active Active
- 2005-12-14 HU HUE10190450A patent/HUE047870T2/hu unknown
- 2005-12-14 LT LTEP10190450.6T patent/LT2292733T/lt unknown
- 2005-12-14 ES ES10190450T patent/ES2763357T3/es active Active
- 2005-12-14 EP EP10190450.6A patent/EP2292733B1/en active Active
- 2005-12-14 PL PL10190450T patent/PL2292733T3/pl unknown
- 2005-12-14 PT PT101904506T patent/PT2292733T/pt unknown
- 2005-12-14 EP EP05817653A patent/EP1831351B1/en active Active
- 2005-12-14 EP EP05817711.4A patent/EP1833962B1/en active Active
- 2005-12-14 HU HUE10192785A patent/HUE039132T2/hu unknown
- 2005-12-14 WO PCT/IL2005/001348 patent/WO2006064504A2/en active Application Filing
- 2005-12-14 AT AT05817653T patent/ATE521699T1/de not_active IP Right Cessation
- 2005-12-14 CA CA2632836A patent/CA2632836C/en active Active
- 2005-12-14 DK DK10190450.6T patent/DK2292733T3/da active
- 2005-12-14 HU HUE05817711A patent/HUE036586T2/hu unknown
- 2005-12-14 WO PCT/IL2005/001345 patent/WO2006064501A2/en active Application Filing
- 2005-12-14 CA CA3016386A patent/CA3016386A1/en not_active Abandoned
- 2005-12-14 SI SI200532268T patent/SI2292733T1/sl unknown
- 2005-12-14 EP EP10192785.3A patent/EP2327761B1/en active Active
-
2006
- 2006-10-17 TW TW095138244A patent/TW200819534A/zh unknown
-
2019
- 2019-12-19 CY CY20191101336T patent/CY1122586T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006064501A2 (en) | 2006-06-22 |
| EP2292733B1 (en) | 2019-09-25 |
| CA2632836C (en) | 2016-09-06 |
| CY1122586T1 (el) | 2021-01-27 |
| WO2006064501A3 (en) | 2007-07-05 |
| EP1831351A2 (en) | 2007-09-12 |
| EP2292733A1 (en) | 2011-03-09 |
| CA3016386A1 (en) | 2006-06-22 |
| EP2327761A1 (en) | 2011-06-01 |
| SI2292733T1 (sl) | 2020-02-28 |
| CA2632836A1 (en) | 2006-06-22 |
| EP1831351B1 (en) | 2011-08-24 |
| LT2292733T (lt) | 2020-03-25 |
| DK2292733T3 (da) | 2020-01-13 |
| ES2763357T3 (es) | 2020-05-28 |
| PT2292733T (pt) | 2020-01-09 |
| EP1831351A4 (en) | 2008-09-03 |
| EP1833962B1 (en) | 2017-11-22 |
| EP2327761B1 (en) | 2018-02-21 |
| CA2632834C (en) | 2018-10-02 |
| TW200819534A (en) | 2008-05-01 |
| PL2292733T3 (pl) | 2020-05-18 |
| EP1833962A4 (en) | 2008-09-03 |
| WO2006064504A2 (en) | 2006-06-22 |
| HUE047870T2 (hu) | 2020-05-28 |
| CA2632834A1 (en) | 2006-06-22 |
| ATE521699T1 (de) | 2011-09-15 |
| WO2006064504A3 (en) | 2007-07-05 |
| EP1833962A2 (en) | 2007-09-19 |
| HUE039132T2 (hu) | 2018-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG152273A1 (en) | Pdx1 expressing endoderm | |
| SG149061A1 (en) | Definitive endoderm | |
| AU3752795A (en) | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof | |
| WO2004044142A3 (en) | Mesenchymal stem cells and methods of use thereof | |
| GB2441939A (en) | Surgical membrane | |
| IL162648A0 (en) | Cellular compositions and methods of making and using them | |
| GB2392674A (en) | Mesenchymal cells and osteoblasts from human embryonic stem cell | |
| WO2004070013A3 (en) | Use of islet 1 as a marker for isolating or generating stem cells | |
| EP1360314A4 (en) | CHEMICALLY DEFINED MEDIUM FOR CULTIVATED MAMMALIAN CELLS | |
| IL150789A0 (en) | Multipotent neural stem cells from peripheral tissues and uses thereof | |
| UA81398C2 (en) | Keratinocytes which may be used as biologically active substances for the treatment of wounds | |
| WO2004003142A3 (en) | Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation | |
| TW200734462A (en) | Regulating stem cells | |
| WO1998051663A3 (en) | 3-epi compounds of vitamin d3 and uses thereof | |
| WO2004029203A3 (en) | Compositions and methods for enrichment of neural stem cells using ceramide analogs | |
| WO2005030040A3 (en) | Hematopoietic stem cell identification and isolation | |
| EP2377922A3 (en) | PDX1 expressing endoderm | |
| ATE473273T1 (de) | Angereicherte zellpopulationen des zentralen nervensystems | |
| HUE039132T2 (hu) | Õssejtek szabályozása | |
| IL177179A (en) | Fusion protein comprising truncated n-acetylgalactosaminyltransferase 2 (galnact2) and maltose binding domain | |
| PL327060A1 (en) | Application of 2-ethylhexyl alpha-cyano-beta,beta-diphemylacrylate to improve stability of cosmetic compositions containing p-methylbenzylibene camphor in combination with a derivative of dibenzoyl methane | |
| AU2158295A (en) | Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using | |
| EP1637591A4 (en) | COMPOSITION FOR STABILIZING THE SURVIVAL OF GRAFTED HEMATOPOIETIC STEM CELL KIT FOR OBTAINING THE COMPOSITION, METHOD FOR STABILIZING THE SURVIVAL OF GRAFTED HEMATOPOIETIC STEM CELL, human monoclonal antibodies OR HUMAN ANTIBODIES of polyclonal AND METHOD FOR PRODUCING THEREOF HUMAN MONOK encoding gene | |
| ATE374243T1 (de) | Knorpelzell-kulturmedium und verwendung desselben | |
| WO2002044344A3 (en) | Basal cell carcinoma cultures, methods related thereto and their use |